INSIGHTS ON LIQUID DOSE MANUFACTURING

• Stability Issues Unique To Liquid Injectables And How To Avoid Them

  Liquid injectables face stability risks like oxidation, hydrolysis, aggregation, temperature shifts, and packaging effects, requiring early, rigorous formulation and process controls.

• Ophthalmic Drug Delivery: Meeting Modern Challenges With A Next Generation Solution

  Ophthalmic injectable packaging demands early strategic attention. Learn how silicone oil contamination, particulate limits, and dosing accuracy challenges can derail development programs and what it takes to stay compliant.

• Establishing A Container Closure System — Engineering For Integrity

  CCS design in aseptic manufacturing involves more than component selection. This article examines how elastomeric closures, barrier configurations, component formats, and plunger placement affect integrity and line performance.

• Extractables, Leachables, And Risk: Ensuring Safety In Pharma Manufacturing

  This session is designed for teams developing new products, optimizing processes, or preparing regulatory submissions, and will provide practical tools for a better approach to E&L management.

• Shaping The Future Of ATMPs: Tailored Automation And Advanced Technologies For The Next Decade

  3/27/2025

  From personalized treatments to large-scale viral vector production, the future of ATMPs hinges on optimized automation. We delve into the technologies driving this transformation and the challenges ahead.

• Maintaining Cell Viability During The Cryovial Filling Process

  4/21/2025

  Maintaining cell viability during cryovial filling is a critical challenge in cell therapy manufacturing. This presentation introduces cryoFIL®, a cutting-edge automated cryovial filling platform designed to deliver high-precision, aseptic, and scalable solutions for cryovial filling.

• Empowering Innovation: Harnessing CDMO Potential For Sterile Injectables

  10/20/2025

  Specialized CDMOs are essential for meeting the growing demand and complex quality requirements for sterile injectables. Outsourcing provides crucial benefits like cost savings, flexibility, and a strategic focus on core competencies.

• Rethinking Fill-Finish To Reduce API Loss In Early Development

  6/15/2026

  Early-stage drug programs can preserve constrained API supplies by replacing large-scale manufacturing defaults with deliberate, right-sized fill-finish designs that minimize avoidable process waste.

• Raise Your Standards With Downflow Booth Airflow Containment

  1/30/2026

  Ensure personnel safety during hazardous material handling by mastering airflow dynamics and containment screens. Learn to achieve low exposure levels through advanced HEPA filtration methods.